Literature DB >> 18845595

Accountability for reasonableness: an update.

Norman Daniels1, James E Sabin.   

Abstract

Mesh：

Year:  2008        PMID： 18845595     DOI： 10.1136/bmj.a1850

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  47 in total

1.  Uncertainty and equipoise: at interplay between epistemology, decision making and ethics.

Authors:  Benjamin Djulbegovic
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

2.  Fairness and legitimacy of decisions during delivery of malaria services and ITN interventions in Zambia.

Authors:  Mary Tuba; Ingvild F Sandoy; Paul Bloch; Jens Byskov
Journal:  Malar J       Date:  2010-11-01       Impact factor: 2.979

3.  Access with evidence development schemes: a framework for description and evaluation.

Authors:  Christopher J McCabe; Tania Stafinski; Richard Edlin; Devidas Menon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  We know accurately only when we know little.

Authors:  Stuart MacLeod; Craig Mitton
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Expensive cancer drugs: a comparison between the United States and the United Kingdom.

Authors:  Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

6.  Budget- and priority-setting criteria at state health agencies in times of austerity: a mixed-methods study.

Authors:  Jonathon P Leider; Beth Resnick; Nancy Kass; Katie Sellers; Jessica Young; Patrick Bernet; Paul Jarris
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

7.  Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective.

Authors:  Kenneth Boyd; Peter Hall
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

Review 8.  The evolution of public health ethics frameworks: systematic review of moral values and norms in public health policy.

Authors:  Mahmoud Abbasi; Reza Majdzadeh; Alireza Zali; Abbas Karimi; Forouzan Akrami
Journal:  Med Health Care Philos       Date:  2018-09

9.  Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial.

Authors:  Mike Paulden; Christopher Mccabe
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

10.  Future unrelated medical costs need to be considered in cost effectiveness analysis.

Authors:  Pieter van Baal; Alec Morton; David Meltzer; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.